Vitura Health Ltd 2023 AR2
The report highlights Vitura Health Limited's record financial growth for the 2023 fiscal year, with revenue increasing by 75% to $117.3 million and profit after tax rising by 129% to $13.8 million. It details the expansion of the company's digital health platform, CanView, which now services over 4,000 pharmacies and nearly 1,500 prescribers. Additionally, the report outlines the establishment of the Cortexa joint venture to supply psychedelic medicines in Australia and the transition of clinic operations to a 100% telehealth model. The company also reports on its ongoing commitment to ESG disclosures aligned with the World Economic Forum's Stakeholder Capitalism Metrics.
Company: Vitura Health Ltd
Sector: Health Care
Country: Australia
Year: 2023
Type: AR2
Pages: 130
Vitura Health Ltd
Annual Report
The report highlights Vitura Health Limited's record financial growth for the 2023 fiscal year, with revenue increasing by 75% to $117.3 million and profit after tax rising by 129% to $13.8 million. It details the expansion of the company's digital health platform, CanView, which now services over 4,000 pharmacies and nearly 1,500 prescribers. Additionally, the report outlines the establishment of the Cortexa joint venture to supply psychedelic medicines in Australia and the transition of clinic operations to a 100% telehealth model. The company also reports on its ongoing commitment to ESG disclosures aligned with the World Economic Forum's Stakeholder Capitalism Metrics.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
Jul 1, 2022 - Jun 30, 2023
Fiscal Year
2023
Published
Oct 27, 2023
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Women on Board
Women in Management
Workplace Fatalities
Employees